Table 2 Comparisons of flow volume (ml) measurements between BH and FB protocols in aortic, pulmonary and tricuspid valve position in healthy subjects (n = 20) and patients with tricuspid regurgitation (n = 25).

From: Free-breathing cardiovascular magnetic resonance flow quantification can be an alternative to standard breath-holding approach

 

BH

FB

MD ± SD

LoA

r

P

AoFF

Total

76 ± 18

74 ± 18

1.4 ± 5.9

-10.1–13.0

0.92

0.11

HS

86 ± 17

85 ± 16

1.4 ± 4.1

-6.6–9.4

0.96

0.15

TR

67 ± 15

66 ± 15

1.5 ± 7.1

-12.4–15.4

0.80

0.30

PuFF

Total

77 ± 19

76 ± 19

0.7 ± 6.2

-11.3–12.8

0.92

0.42

HS

88 ± 18

88 ± 17

0.41 ± 3.5

-6.4–7.3

0.96

0.60

TR

68 ± 15

66 ± 14

1.0 ± 7.7

-14.1–16.1

0.82

0.18

TrIF

Total

88 ± 21

91 ± 24

-3.2 ± 6.2

-15.3–8.9

0.96

0.01

HS

84 ± 18

85 ± 19

-0.89 ± 4.1

-8.9–7.1

0.95

0.34

TR

90 ± 24

95 ± 26

-5.1 ± 7.0

-18.7–8.6

0.95

0.001

  1. AoFF, aortic forward flow volume; BH, breath-holding; FB, free-breathing; HS, healthy subjects; LoA, limits of agreement; MD, mean difference of BH-FB; PuFF, pulmonary forward flow volume; SD, standard deviation; Total, the entire study population; TrIF, tricuspid inflow volume; TR, patients with tricuspid regurgitation.